ArticleCureus2023
Current Status of Dermatophytosis: A Hospital-Based Study in Northern Odisha, India.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Dermatophytes: Update on Clinical Epidemiology and Treatment.Mycopathologia · 2024Review
- A Cross-sectional Study Comparing theIndian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Dermatophytosis is a superficial mycosis that affects the keratinized structures of skin, hair, and nails. In recent years, there has been a marked rise in superficial fungal infections in several parts of our country. Most of the cases are presented with chronic, recurrent, and resistant infections. There are no comprehensive data on the status of cases in our area. Currently, we have noticed a gradual decline in the number of cases in our day-to-day outpatient department compared to previous years. Therefore, the current retrospective study was conducted to assess the actual status and clinico-demographic trends of dermatophytosis among patients who visited the tertiary care hospital. Methods The current study is a retrospective study of 78,028 patients of dermatophytosis who reported to the tertiary care hospital. Data like demographic details, clinical examination findings, and laboratory investigation reports of patients were extracted from available records year-wise from 2018 to 2022. Results There was an initial rise of dermatophytosis until 2019 and, thereafter, a downward trend. Males (60.04%) outnumbered females (39.94%) with a proportion of 1.5:1. Most common age group belongs to 21-30 years (28.64%), of which a majority (53.07%) of patients had a disease duration of more than three months. The majority of patients (51.1%) belong to rural backgrounds, but there was urban predominance following the coronavirus disease (COVID-19) pandemic. The most common organism isolated from culture was
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.